We found that RNASET2 and ABCG1, significantly differentially expressed in RCC patients compared to NCs under the standard with p < 0.01 and |log2FC| Cutoff > 1.5, were considered potential target genes of the four-miRNA panel (Figures 5B,C). This evidence concerns the gene RNASET2 and renal cell carcinoma.